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Abstract
Background: The causative agent of Chagas disease, Trypanosoma cruzi, is divided into 6 Discrete Typing Units (DTU): Tc I,
IIa, IIb, IIc, IId and IIe. In order to assess the relative pathogenicities of different DTUs, blood samples from three different
clinical groups of chronic Chagas disease patients (indeterminate, cardiac, megacolon) from Bolivia were analyzed for their
circulating parasites lineages using minicircle kinetoplast DNA polymorphism.
Methods and Findings: Between 2000 and 2007, patients sent to the Centro Nacional de Enfermedades Tropicales for
diagnosis of Chagas from clinics and hospitals in Santa Cruz, Bolivia, were assessed by serology, cardiology and gastro-
intestinal examinations. Additionally, patients who underwent colonectomies due to Chagasic magacolon at the Hospital
Universitario Japone ´s were also included. A total of 306 chronic Chagas patients were defined by their clinical types (81 with
cardiopathy, 150 without cardiopathy, 100 with megacolon, 144 without megacolon, 164 with cardiopathy or megacolon,
73 indeterminate and 17 cases with both cardiopathy and megacolon). DNA was extracted from 10 ml of peripheral venous
blood for PCR analysis. The kinetoplast minicircle DNA (kDNA) was amplified from 196 out of 306 samples (64.1%), of which
104 (53.3%) were Tc IId, 4 (2.0%) Tc I, 7 (3.6%) Tc IIb, 1 (0.5%) Tc IIe, 26 (13.3%) Tc I/IId, 1 (0.5%) Tc I/IIb/IId, 2 (1.0%) Tc IIb/d
and 51 (25.9%) were unidentified. Of the 133 Tc IId samples, three different kDNA hypervariable region patterns were
detected; Mn (49.6%), TPK like (48.9%) and Bug-like (1.5%). There was no significant association between Tc types and
clinical manifestations of disease.
Conclusions: None of the identified lineages or sublineages was significantly associated with any particular clinical
manifestations in the chronic Chagas patients in Bolivia.
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Introduction
Despite concerted efforts to control Chagas disease in Bolivia,
the prevalence of Trypanosoma cruzi remains high [1]. For example,
one study has shown that in the village of Tarija, South Bolivia,
the prevalence in pregnant women can reach up to 33.9% [2].
Furthermore, the vector infection rate of triatomines in the
southern zone of Cochabamba, in the center of Bolivia, was found
to be 79%, which translates to a very high infection risk for
children in this area [3]. In addition, seroprevalence studies in
Santa Cruz, in the east of Bolivia, recorded parasite exposure
positive rates of 50% and concluded that there was a significant
risk of infection via blood transfusion [4,5,6].
The chronic stage of Chagas disease may be categorized into
three major clinical forms; those involving cardiopathy, digestive
tract pathology (such as megacolon), and indeterminate (asymp-
tomatic) forms [7,8]. There appears to be geographical variation
in the development of these clinical forms in Latin America, but in
Bolivia all three clinical forms are observed [8,9,10,11,12].
This variation in pathological manifestation has been reported
to be related to differences in the efficiency of the human host’s
immune response, such as ability to control parasitemia, the
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autoimmune responses [13,14,15]. However, the host factors
underlying the mechanisms of the outcome of the disease remain
undetermined. Another possible factor that determines the clinical
course of Chagas is the pathogenicity of T. cruzi itself. The genetic
polymorphism of T. cruzi population may be related to its
variability in pathogenicity. As there is no sexual stage in the
parasite’s life cycle (although some genetic exchange might occur)
[16], the majority of parasites belong to clonal lineages. Population
genetic studies of T. cruzi, carried out by zymodeme, ribosomal
RNA, miniexon, and genomic DNA analyses, have revealed two
primary phylogenetic lineages [17,18,19]. Within the last few years
there has been an attempt to standardize the nomenclature.
Trypanosoma cruzi is divided into 6 Discrete Typing Units (DTU)
TcI, TcIIa, TcIIb, TcIIc, TcIId and TcIIe [20,21,22,23,24,25].
Geographical and epidemiological studies showed that the
distribution of TcI and TcII vary geographically. TcI is prevalent
in the northern part of Brazil, Central and North America
[26,27,28] while TcII is found predominantly in Southern cone
countries of Latin America [29,30]. In Bolivia, the TcIId was
found to be the most common [30]. Furthermore, Virreira et al,
2006 [31] further sub-divided the TcIId based on patterns of
minicircle Hypervariable Region (HVR), classifying three subdi-
visions as Mn-like, Bug-like and TPK-like.
In this study, in order to elucidate parasite factors that might
influence the outcome of clinical disease, we have systematically
classified our Bolivian patients according to their Chagas-related
clinical symptoms (indeterminate, cardiopathy and megacolon)
and determined the lineages of circulating parasites in their blood
using PCR amplification.
Materials and Methods
Patients
Three hundred and six outpatients with chronic Chagas disease
(144 men and 162 women, mean age 44.7 years) were recruited
from Centro Nacional de Enfermedades Tropicales (CENE-
TROP) (120 men and 132 women), and from inpatients and past
patients at the Hospital Universitario Japone ´s (HUJ) (24 men and
30 women) in Santa Cruz, Bolivia. CENETROP was functioning
as a National Center for the diagnosis of Chagas, and so patients
were sent from outpatient clinics in Santa Cruz. Upon medical
examination of patients, if serological tests (Indirect Haemagglu-
tination test (IHA) and Indirect Immunofluorescence test (IIF) [1])
were positive, they were asked to participate in the study and
informed consent was obtained. In order to collect a larger sample
size of patients with megacolon, post-surgical operational mega-
colon patients with retrospective seropositivity were also recruited
to the study following the same procedure as at CENETROP. As
the majority of the patients were infected from childhood, their
original birth places were recorded. Within 306 subjects, 203 were
originally from Santa Cruz, 1 from Beni, 37 from Cochabamba, 6
from La Paz, 3 from Oruro, 33 from Chuquisaca, 10 from Potosi,
12 from Tarija, and 1 who did not born in Bolivia.
For all the CENETROP participants, Electrocardiogram (ECG)
at CENETROP, and X-ray of colon following barium enema at
Clinica Siranı ´, Santa Cruz, Bolivia were performed. For the HUJ
past patients with megacolon, we retrospectively checked their
ECG abnormalities, macroscopic observation of colon pathology
and serological tests.
ECG examination was performed using an automated ECG
analyzer (Nihon-denshi, Tokyo, Japan) and ECG abnormalities
were diagnosed base on Minnesota Code Criteria [32,33]
(Table 1). All the ECG records were checked and confirmed
independently by two cardiologists (AG and LAR). Colon X-ray
with barium enema examination was performed for the detection
of megacolon as previously described [34]. No achalasia like
symptoms was observed in any patients and barium enhanced X-
ray examination for megaesophagus was not performed. ECG and
Barium enema X-ray examinations were performed for all
participants except for the post operational patients with
megacolon. To exclude the possibility of including an asymptom-
atic person as an indeterminate form who did not have enough
time to develop complications, asymptomatic patients who were
less than 30 years old were excluded from the study.
The experimental protocol was approved by the Institutional
Ethical Review Committee at the Institute of Tropical Medicine,
Nagasaki University (No. 0210170018) and at the Centro
Nacional de Enfermedades Tropicales (CENETROP). Written
informed consent was obtained from all subjects.
Blood culture, DNA extraction and PCR conditions
Three ml of heparinized blood were cultured in 7 ml of liver
infusion tryptose (LIT) Becton Dickinson, MA,USA) medium
supplemented with 10% Fetal Calf Serum (Invitrogen, CA, USA)
and 0.05% Hemin (Sigma-Aldrich Inc., St. Louis, USA) for more
than 3 months and, microscopically checked for the parasite
growth, as previously described [35].
Genomic DNA was extracted from 10 ml of whole blood
containing 10 mM ethylene diamine tetra acetic acid (EDTA)
using a DNA extraction kit (QIAGEN GmbH, FRG) and was
stored at 220uC.
PCR amplification was performed with two primer sets to detect
T. cruzi genomic and mitochondrial DNA: Tcz1 (CGAGC-
TCTTGCCCACACGGGTGCT)/Tcz2 (CCTCCAAGCAGC-
GGATAGTTCAGG) for detection of genomic satellite DNA
[36], 121 (AAATAATGTACGGGKGAGATGCATGA)/122 (G-
GTTCGATTGGGGTTGGTGTAATATA) for minicircle kDNA
[30]. PCR was carried out in a total volume of 30 ml containing
16 buffer, 2 mM MgCl2, 0.2 mM dNTPs, and 1 mM each
primer, 0.15 units of Taq polymerase (Takara Bio INC, JPN)
and 150 ng of sample DNA. The PCR condition for Tcz1/
Author Summary
Around 30–50% of Trypanosoma cruzi infections in Latin
America cause chronic Chagas disease 10–30 years after
the primary infection due to lack of effective treatment.
The major clinical complications associated with chronic
Chagas disease are cardiac myositis (leading to cardiac
failure), and autonomous neuroplexus degeneration of the
digestive tract that can cause megacolon or megaesoph-
agus. Therefore, there are three major clinical forms of
Chagas disease; cardiac, digestive and indeterminate
(asymptomatic). The parasites, which can infect humans
as well as other mammals, are transmitted by species of
triatomines commonly found in the Americas. The parasite
is divided in at least six discrete typing units: TcI, TcIIa–e. In
humans, the TcI is mainly observed in Central America and
northern parts of South America while the TcIIb/d/e is
confined mainly to the southern cone of Latin America. We
determined which DTU were prevalent in chronic patients
in Bolivia, where the three clinical forms and several DTUs
of the parasites are present, in order to determine whether
there was a link between a particular parasite DTU and a
particular clinical outcome. We found a vast majority of
TcIId but its kDNA polymorphism showed no association
with any of the clinical manifestations of chronic Chagas.
T. cruzi and Clinical Forms of Chagas Disease
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[37,38].
DTUs analysis
Analysis of the lineage of T. cruzi was carried out by a
sequence- specific oligonucleotide probe (SSOP) method [39].
Briefly, 2 ml of the amplified kinetoplast minicircle hypervariable
region (kDNA) was blotted on positively-charged nylon mem-
branes (Roche Diagnostics K.K, CH) and were UV- crosslinked
for fixation after alkaline treatment. Ten micromole of the biotin
labeled HVR domain of TcI or TcII (b, d, e) SSOPs were
hybridized on a 6 cm68 cm square membrane containing
sample dots in 10 ml of hybridization buffer containing 50 mM
Tris-HCl pH8, 0.3 M Tetramethylammonium Chloride
(TMAC), 2mM EDTA, 56 Denhart’s Solution (100 ml of 2%
PVP, 2% Ficoll-400 and 2g of BSA), 0.1%SDS and 1 mg
sonicated salmon sperm DNA at 56uC for 3 hours. Detection was
performed by the Southern Light CSPD (TROPIX Inc. Bedford
MA, USA) chemiluminescence method. The image was captured
by Luminescent Image Analyzer, Image Reader LAS-4000 mini
( F u j i f i l mK .K ,J a p a n ) .
For the detection of TcI parasites, biotin labeled whole PCR
fragment of kDNA-HVR of the strain Ab4-1 (TcI) was used for
a hybridization probe, as previously described [39,40]. For TcII
parasites, six probes were prepar e df o rT c I I ba n do n ef o rT c I I e .
Because TcIIa and TcIIc have been rarely observed in human
patients, probes specific to these types were not used [41].
BLAST search allowed the construction of 6 oligonucleotides
with high homology for TcIIb kDNA-HVR. The accession
numbers correspond to the sequences in which the probes were
d e s i g n e d .O l i g oA( G T AG T TT A AG A TA A TA T CA T GT )
(accession numbers: AJ747981, AJ747979, AJ747978), Oligo B
(ATA GTT AAT TAT AGA ATA TTC TG) (accession
number: AJ747983), Oligo C (TGA TAA CGT ATG TAT
TAT GTT GA) (accession number: AJ747975), Oligo D (TAT
AAT TAT GTA TAT CTT AAT GT) (accession number:
AJ747977), Oligo E (TAT ATA TCT GAG TTA CTG TTG)
(accession number: AJ747080, AJ747976) and Oligo F (TAT
GGA GAC ATA GAA TTG AGT A) (accession number:
AJ747995, AJ747994, AJ747992, AJ747991, AJ747990). BLAST
search allowed the construction of Oligo H (TAA GAC ATG ACA
TAA TAC AAT) from a sequence with high homology for TcIIe
kDNA-HVR (accession numbers: AJ748068, AJ748061 and
AJ748053). Detection of TcIId was performed with the Oli 1
and Oli 2 probes previously described [31]. The hybridization
patterns obtained by the combination of those probes, Oli1+/
Oli22,O l i 1 2/Oli2+ and Oli+/Oli2+, were used for classification
of the TcIId subtypes, Bug-like, Mn-Like and TPK-like respec-
tively.
The strains PH 1 (TcIIa), PH 2 (TcIIa) [42] were used as
negative controls for the probes. The strains Bernice (TcIIb), Tul-
L (TcIIb), Y (TcIIb) and Ab-3-8 (TcIId) [16] were used as positive
controls. The hybridization profiles obtained with the probes are
presented supplementary data (Figure S1).
Statistical analysis
Two-tailed Chi square tests were used to determine the
significance of associations between parasite type and clinical
manifestations of disease. Contingency tables were used to
determine the odds ratio (OR) and a 95% confidence interval
(CI) by Woolf’s formula.
Results and Discussion
Clinical identification of seropositive chronic patients
All patients (n=306) were serologically positive. Out of 231
ECG examinees, 81 patients (35.1%) had cardiac abnormalities as
identified by electrocardiogram (38 men and 43 women, mean age
41.0 years, age range 22–72). One hundred patients had
megacolon as determined by barium enema X-ray examination
(n=45) or by the macroscopic observation at the surgical
operation (n=55) (50 men and 50 women, mean age 51.3 years,
age range 17–89). Out of 189 barium enema examinees, 45
(23.8%) were diagnosed megacolon and 21 patients (46.7%) out of
the 45 megacolon patients showed elongation of the sigmoid colon
[43]. Out of 114 patients who had both ECG and barium enema
X-ray examinations, 73 patients (64%) without any complications
after the above mentioned examinations were deemed indetermi-
nate cases (34 men and 39 women, mean age 42.3 years, age range
29–65) (Table 2).
Table 1. ECG abnormalities observed in chronic Chagas
patients.
ECG abnormality N=64
ECG abnormality
with megacolon N=17
cRBBB 12 MI 1
cRBBB, LAFB 1 iRBBB 2
cRBBB, LVH 1 cRBBB 3
cRBBB, SB 2 cRBBB, LAFB 3
iRBBB 9 sMI 1
iRBBB, SB 1 RVCD 1
AVB-1st 3 LAE, SB 1
AVB-2nd 1 PAC 1
MI 1 Short PR interval 1
sMI, RAD 1 cLBBB 1
iMI 1 LAFB, RVCD 1
aMI 2 AF 1
aMI, LAFB, 1
asMI, LAFB 1
SB 3
ST 1
LAD 5
LAD, RVCD 2
SAR 1
ICD 2
cLBBB 3
LAE 1
RVCD 7
LVH 1
T wave abnormalities 1
cRBBB; complete right bundle branch block, LAFB; left anterior fascicular block,
LVH; left ventricular hypertrophy, SB; sinus bradycardia, iRBBB; incomplete right
bundle branch block, AVB-1
st; first degree AV block, AVB-2
nd; second degree AV
block, MI; myocardial infarction, sMI; septal myocardial infarction, RAD; right
axis deviation, iMI; inferior myocardial infarction, aMI; anterior myocardial
infarction, asMI; anteroseptal myocardial infarction, ST; sinus tachycardia, RVCD;
right ventricular conduction delay, SAR; sinus arrhythmia, ICD; intraventricular
conduction delay, cLBBB ;complete left bundle branch block, LAD; left axis
deviation, LAE; left atrial enlargement, PAC; premature atrial contraction, AF;
atrial fibrillation.
doi:10.1371/journal.pntd.0000687.t001
T. cruzi and Clinical Forms of Chagas Disease
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by species specific primers
In acute Chagas disease, detection of parasite DNA is
feasible due to high parasitemia, whereas in Chronic Chagas it
is more difficult because of the generally lower parasitemia
[44]. Using kDNA PCR products, we could detect circulating
parasite genomic DNA from 64.1% of the samples and could
analyze in detail the lineages of 47.4% of the 306 seropositive
chronic patients as shown in Table 2. Tcz1/Tcz2 primer set
for genomic satellite DNA detected 77.8% whereas the 121/
122 primer that target the minicircle kDNA showed a lower
sensitivity.
Three ml of blood samples were cultured from all the 306
seropositive samples, however, only two isolates were obtained
after 2–3 months culture. These two isolates from a 50 year old
male and a 52 year old female were named SCBOL1 and
SCBOL2 respectively. Both these parasites were determined to be
TcIId.
No significant deviation between the PCR negative samples and
the categorized form of the disease was observed.
Characterization of T. cruzi DTU I and II sublineages by
minicircle kDNA HVR analysis
The minicircle kinetoplast is present at about 5000 copies per
parasite and each minicircle has four hypervariable regions that
correspond to families of specific DTU. These sequences were
targeted for detection of clones of TcI and TcIId in previous work
[30]. In this work, minicircle kDNA amplification allowed the
identification of 64.1% (196 out of 306) of the seropositive chronic
Chagas patients. Out of those 196 samples, 133 (68.0%) were
identified as TcIId, 31 (15.8%) TcI, 10 (5.1%) TcIIb and 1 (0.5%)
TcIIe (Table 3). Double or triple infection with Tc I/IId (26 out of
196), Tc I/IIb/IId (1 out of 196) or Tc IIb/IId (2 out of 196) was
also detected. The remaining undefined samples (26.0%) could be
due to the limitation of detection by the probes. It is possible that
these clones may have a unique, as yet undescribed genotype
which was not detected by the probes used in this study.
There was no significant difference between those TcI, IIb, IId
and IIe distribution in the clinical groups, as shown in Table 3.
However, these data partially support previous reports that TcI is
predominantly observed in triatomines but not in elderly humans
Table 2. Clinical manifestations of the subjects and their circulating parasite detection by PCR.
ECG Abnormality Megacolon
No. of
patients Male Female Age
121/122
PCR(+)
a (%)
Mean ± SD
2 2 73 34 39 42.3 6 8.5 57.5
2 NE
b 41 16 25 42.9 6 9.6 61.0
+ NE 21 10 11 40.6 6 10.4 52.4
+ 2 43 22 21 38.5 6 9.8 72.1
+ + 17 6 11 47.9 6 14.1 52.9
2 + 36 17 19 47.1 6 12.0 55.6
NE + 47 27 20 55.6 6 17.0 80.9
NE 2 28 12 16 42.5 6 7.4 71.4
Total 306 144 162 44.7 ± 12.4 64.1
aAmplification of the minicircle kinetoplast hypervariable region for further lineages analysis.
bNot Examined: The subjects had no test of ECG or colon enema X ray.
doi:10.1371/journal.pntd.0000687.t002
Table 3. Clinical manifestations and identified DTUs.
ECG
abnormality
Mega-
colon
Examined
Number
TcI
n( % )
TcIIb
n( % )
Tc I/IId
n( % )
Tc I/IIb/IId
n( % )
Tc IIb/IId
n( % )
TcIId
n( % )
TcIIe
n( % )
UND
a
n( % )
2 2 42 0 (0.0) 1 (2.4) 8 (19.0) 0 (0.0) 0 (0.0) 24 (57.1) 0 (0.0) 9 (21.4)
2 NE
b 25 0 (0.0) 0 (0.0) 1 (4.0) 0 (0.0) 0 (0.0) 20 (80.0) 0 (0.0) 4 (16.0)
+ NE 11 0 (0.0) 0 (0.0) 2 (16.7) 0 (0.0) 0 (0.0) 6 (54.3) 0 (0.0) 3 (25.0)
+ 2 31 0 (0.0) 2 (6.3) 4 (12.5) 0 (0.0) 0 (0.0) 14 (43.8) 1 (3.1) 10 (32.3)
+ + 8 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5) 4 (50.0) 0 (0.0) 4 (44.4)
2 + 20 0 (0.0) 0 (0.0) 3 (15.0) 0 (0.0) 1 (5.0) 11 (55.0) 0 (0.0) 5 (25.0)
NE + 38 4 (10.5) 3 (7.9) 4 (10.5) 1 (2.6) 0 (0.0) 17 (44.7) 0 (0.0) 9 (23.7)
NE 2 20 0 (0.0) 1 (5.0) 4 (20.0) 0 (0.0) 0 (0.0) 8 (40.0) 0 (0.0) 7 (35.0)
Total 196 4 (2.0) 7 (3.6) 26 (13.3) 1 (0.5) 2 (1.0) 104 (53.1) 1 (0.5) 51 (26.0)
aUnidentified Tc, those amplified minicircle DNA did not hybridize with any of the probes.
bNot Examined: The subjects had no test of ECG or colon enema X ray.
doi:10.1371/journal.pntd.0000687.t003
T. cruzi and Clinical Forms of Chagas Disease
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[29,30,45] and in Argentina [44].
TcIId subtype
Among the 133 TcIId samples that were positive with either
Oli1 and/or Oli2 TcIId probes, 49.6% were Mn-like (Oli12/
Oli2+), 48.9% were TPK1-like (Oli1+/Oli2+) and 1.5% were
Bug-like (Oli1+/Oli22) (Figure S1). For the analysis of TcIId, the
method reported by Virreira et al, 2006 using kDNA polymor-
phism was followed [31]. They observed that the three subtypes of
TcIId, TPK1-like, Bug-like and Mn-like were almost equally
distributed in 39 cord blood samples collected in Cochabamba and
Tarija, Bolivia. While in our study, only two samples (1.5%) of the
Bug-like type were detected as shown in Table 4. The reason for
the low frequency of the bug-like in the present study may be due
to the geographical difference between central and south in
Bolivia. Another reason may involve the origin of blood samples;
in the previous study [31], samples were from new born cord
blood from infected mothers, whereas in the present study blood
was obtained from adult patients with chronic infections.
Our results imply that the clinical manifestations of chronic
Chagas disease (defined as cardiopathology, megacolon or
indeterminate), are not correlated with parasite lineage or
subgroup types of TcIId (Table 4). It has been proposed that a
genetic mutation occurred following the divergence of the
subgroups of TcIId that altered parasite pathogenicity. Given
this, it is important that further parasite genetic characterization
and association studies with clinical pathology are carried out.
Several important genes that may be involved in the invasion,
proliferation and immune evasion of these parasites have been
identified [46,47], and these would be obvious candidate genes for
pathogenicity association studies.
The first paper that suggested differences in clinical spectrum by
strain type was given by Miles et al that a markedly contrast
between the main zymodemes observed in Venezuela (Z1=TcI)
and Brazil (Z2=TcII) could explain the absence and presence of
gastrointestinal Chagas respectively in the regions [48]. The lack
of association between DTU and clinical picture in the present
study can be explained by the reason that there was not enough
heterogeneity in the genetic makeup of the parasites in this
geographical area to provide the statistical power to demonstrate a
difference. Therefore our study further supports the hypothesis
that large-scale differences in clinical manifestations (presence or
absence of GI megasyndromes) may be due to large genetic
differences (Type I vs II, southern Brazil vs Venezuela) but that
within a geographic area where one or 2 DTUs predominate as
observed here, the differences are due to host factors.
In conclusion, the TcIId lineage was shown to be involved in the
pathogenesis of a variety of clinical manifestations of chronic
Chagas disease in Bolivia, but the subtypes of TcIId were not
associated with any of the clinical forms.
Supporting Information
Figure S1 Ten hybridization membranes using different probes
for detection of DTU lineage, sublineage and subgroup are shown.
The probes used here were as follows; A: Oli 1 (DTU IId), B: Oli2
(DTU IId), C–H: probes A, B, C, D, E, F (DTU IIb), I: probe H
(DTU IIe) and J: DTU I.
Found at: doi:10.1371/journal.pntd.0000687.s001 (0.30 MB
DOC)
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